Nicola Borthwick

Nicola Borthwick is a Post-doctoral Immunologist at the Nuffield Department of Medicine, University of Oxford, actively contributing to the HIV Vaccine Programme. Her work bridges laboratory research and clinical applications in HIV immunology.

Her research centers on HIV vaccine development with emphasis on T-cell immunology, viral vector systems, and conserved region targeting. Key investigations include HLA-E peptide interactions, DNA vaccine platforms, and neutralizing antibody induction through adenovirus/MVA vectors. She explores mechanisms of immune evasion and strategies to elicit durable responses against HIV-1.

Analysis of her publication record reveals consistent focus on translational HIV vaccinology, integrating clinical trial data with molecular immunology. Her work demonstrates progression from peptide-level studies to complex vaccine regimens, highlighting the interplay between innate and adaptive immunity in HIV protection.

As part of Oxford's HIV Vaccine Programme, Dr. Borthwick collaborates within multidisciplinary teams conducting laboratory analyses and clinical trial support for next-generation HIV vaccine candidates.